Maxillary prognathism

K11_MAXIL_PROGN

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K07.12 Hospital discharge: ICD-10 — K07.12 Cause of death: ICD-10 — K07.12 3 out of 7 registries used, show all original rules.	201
4. Check minimum number of events None	201
5. Include endpoints None	201
6. Filter based on genotype QC (FinnGen only)	192

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_MAXIL_PROGN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K0712
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K0712
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K0712
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Maxillary prognathism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	6411	3406	3003
Only index persons	5160	2752	2408
Unadjusted period prevalence (%)
Whole population	0.09	0.10	0.08
Only index persons	0.10	0.10	0.09
Median age at first event (years)
Whole population	10.33	10.28	10.38
Only index persons	11.14	11.11	11.18

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	192	129	63
Unadjusted period prevalence (%)	0.04	0.05	0.03
Median age at first event (years)	30.49	28.89	33.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
201: Matched controls
2010

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K07.12

ICD-10 Finland

Prognathism (mandibular)(maxillary)

+∞

291.0

201

K07.13

ICD-10 Finland

Retrognaty, mandibular

51.8

143.1

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

18.3

95.5

101

105

EB1MA

NOMESCO Finland

Cephalometry with X-ray

16.2

88.9

104

125

SBB10

NOMESCO Finland

Dental impressions

14.1

79.9

141

287

SAA04

NOMESCO Finland

Special examination of mouth

13.6

78.1

103

144

K07.23

ICD-10 Finland

Deep bite

14.0

74.3

108

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

17.6

69.4

SJD10

NOMESCO Finland

Placement of orthodontic arch wire

12.0

68.8

142

SJD00

NOMESCO Finland

Removal and/or reactivation of orthodontic arch wire

11.3

63.3

135

SJC10

NOMESCO Finland

Orthodontic band in one tooth

11.7

62.4

114

EDC10

NOMESCO Finland

Sagittal osteotomy of ramus of mandible

197.4

57.3

SJC50

NOMESCO Finland

Removal of fixed orthodontic appliance with at least 7 brackets

10.3

54.1

117

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

9.5

53.8

146

SJD20

NOMESCO Finland

Placement of modified orthodontic arch wire

10.5

52.0

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

9.0

43.0

101

K07.60

ICD-10 Finland

Snapping jaw

10.1

42.2

K07.24

ICD-10 Finland

Open bite

18.1

41.9

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

7.0

39.6

191

K07.20

ICD-10 Finland

Crossbite (anterior)(posterior)

12.2

38.8

SJD30

NOMESCO Finland

Demanding placement of orthodontic arch wire

10.1

36.6

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

7.6

36.5

116

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

8.3

36.5

SJD40

NOMESCO Finland

Placement of prefabricated palatal or lingual arch

6.5

31.7

141

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

11.6

31.2

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

6.0

30.2

165

K07.11

ICD-10 Finland

Retrognathism (mandibular)(maxillary)

90.8

28.7

SJB60

NOMESCO Finland

Adjustment and grinding of removable appliance

6.8

28.1

SXC05

NOMESCO Finland

Other oral or dental procedure

4.8

24.3

221

SAA03

NOMESCO Finland

Extended examination of mouth

5.5

23.1

163

877

K07.22

ICD-10 Finland

Anomalies of dental arch relationship

19.5

21.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

4.3

20.4

144

747

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

4.8

19.6

143

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

4.7

19.4

149

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

6.0

19.2

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

5.6

18.7

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

5.9

17.9

SJC40

NOMESCO Finland

Removal of fixed orthodontic appliance with at most 6 brackets

4.4

17.6

150

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

4.6

17.4

136

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

3.8

15.1

194

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

13.4

15.1

SAC01

NOMESCO Finland

Separate planning of oral and dental treatment, standard

4.7

15.1

K07.14

ICD-10 Finland

Retrognaty, maxillary

27.6

15.0

SJB10

NOMESCO Finland

Fitting of removable appliance incl. patient instructions, demanding

6.1

14.4

EBB10

NOMESCO Finland

Insertion of dental implant

30.7

13.2

SJB30

NOMESCO Finland

Extraoral traction arrangements and operation instruction, removable appliance

6.1

12.9

SJD50

NOMESCO Finland

Placement of prefabricated palatal or lingual arch, dentist-made

11.1

11.8

SJX20

NOMESCO Finland

Orthodontic treatment/control appointment

3.8

11.7

122

WZC00

NOMESCO Finland

Treatment plan or consultation

2.7

11.2

110

614

K07.18

ICD-10 Finland

Another anomaly in the relationship between jaw and skull base

115.8

10.5

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

21.4

9.9

EEC05

NOMESCO Finland

Le Fort I osteotomy

57.9

9.7

EBB15

NOMESCO Finland

Insertion of dental implant abutment

57.9

9.7

WZA90

NOMESCO Finland

Other medical or dental certificate

2.5

8.7

428

WX704

NOMESCO Finland

Intubation

3.7

8.1

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

23.1

8.1

K07.10

ICD-10 Finland

Asymmetry of jaw

23.1

8.1

WX725

NOMESCO Finland

Noninvasive ventilation

4.8

8.1

SAC03

NOMESCO Finland

Separate planning of oral and dental treatment, very demanding

10.6

7.7

OIKK, ,

NOMESCO Finland

2.9

7.6

152

SJA02

NOMESCO Finland

Workplan for orthodontic treatment

83.0

7.5

SPC20

NOMESCO Finland

Implant borne crown

83.0

7.5

K07.1

ICD-10 Finland

Anomalies of jaw-cranial base relationship

83.0

7.5

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.9

7.4

148

SCD01

NOMESCO Finland

Removal of biofilm and supragingival calculus, short

8.4

7.2

SPAT1324

SPAT

Screening procedure

2.6

7.1

222

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

8.8

7.0

SJC00

NOMESCO Finland

Bondable bracket or other fixed attachement

23.4

6.7

SPC10

NOMESCO Finland

Standard dental crown

14.9

6.5

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

7.4

6.3

SPB10

NOMESCO Finland

Manufacture of a temporary crown to tooth at the dental office

27.6

6.3

SPAT1263

SPAT

Sampling

2.1

6.1

100

646

SFA00

NOMESCO Finland

Small restoration

2.6

6.0

158

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

5.00

11.32

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

129

3.51

10.05

6.3

5.1

—

(40761535) Cells panel - Urine sediment

3.21

6.27

3.2

3.4

—

(3019150) Specific gravity of Urine by Refractometry

350

2.07

4.97

4.1

3.1

1.01

1.02

kg/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.76

3.22

2.7

2.5

39.38

94.46

ng/l

1.34

(3047181) Lactate [Moles/volume] in Blood

3.58

3.16

5.3

5.6

1.16

1.09

mmol/l

0.25

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2.81

3.13

8.6

8.8

24.55

24.93

mmol/l

0.25

(3021589) Normoblasts [#/volume] in Blood

773

0.59

2.80

8.1

9.0

0.00

e9/l

0.50

622

(3015736) pH of Urine

601

1.62

2.72

3.7

2.9

5.58

5.81

—

(3007853) Bacteria identified in Skin by Aerobe culture

152

1.98

2.59

1.3

1.7

—

(40758558) Short blood count panel - Blood

437

0.51

2.57

6.9

6.6

—

(3044640) Blood type and Crossmatch panel - Blood

443

0.53

2.46

2.5

2.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

373

1.65

2.45

2.9

2.7

12.81

20.40

ng/l

1.45

196

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

409

1.63

2.41

2.5

56.67

57.69

u/l

0.08

385

(3019060) Gas panel - Arterial blood

2.60

2.41

7.0

5.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

146

1262

1.57

2.15

4.8

3.8

14.55

14.41

pmol/l

0.32

136

1165

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

331

0.50

2.14

2.7

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

573

1.52

2.13

4.1

3.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

164

1.82

2.08

1.4

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

123

1029

1.50

2.07

3.8

—

(4200892) Spirometry reversibility

105

2.00

2.04

1.5

1.3

—

(3002256) Pathology report gross observation

169

0.39

1.88

1.0

1.1

—

(3044889) 12 lead EKG panel

112

934

1.45

1.82

3.5

2.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.57

1.76

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

170

1549

1.63

1.73

10.2

10.9

3.93

3.91

mmol/l

0.49

170

1498

(3035350) Ketones [Presence] in Urine by Test strip

734

1.41

1.59

4.0

3.2

0.00

0.01

estimate

—

153

(3021601) Nitrite [Presence] in Urine by Test strip

728

1.40

1.53

5.2

4.4

0.00

estimate

—

149

(3007164) IgA [Mass/volume] in Serum or Plasma

490

0.65

1.47

1.3

1.4

1.93

2.03

g/l

0.20

288

(3020891) Body temperature

2.43

1.47

4.7

4.9

—

(3029937) Albumin [Presence] in Urine by Test strip

389

1.45

1.46

4.7

3.4

0.13

0.00

estimate

—

147

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.18

1.44

1.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

303

1.49

1.41

2.4

2.6

0.53

1.15

mg/l

1.26

219

(3019550) Sodium [Moles/volume] in Serum or Plasma

168

1549

1.52

1.37

10.5

10.8

139.85

139.72

mmol/l

0.33

168

1505

(3026389) Candida sp identified in Specimen by Organism specific culture

2.99

1.36

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

1.36

0.0

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

426

0.65

1.34

3.0

14.51

40.68

e6/l

1.06

324

(40768793) Breast Pathology biopsy report

0.00

1.34

0.0

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

2.82

1.29

1.0

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.82

1.29

1.0

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

2.82

1.29

1.0

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

365

0.64

1.27

6.3

4.9

96.76

93.44

0.38

359

(3009261) Glucose [Presence] in Urine by Test strip

737

1.35

1.25

4.0

3.2

0.13

0.00

estimate

—

146

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.67

1.22

3.2

1.7

12.60

13.44

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.67

1.22

1.0

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

221

0.56

1.21

2.2

2.8

18.87

3.48

e6/l

—

114

(21494755) Public health laboratory ask at order entry panel

200

1.53

1.21

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

476

1.37

1.20

3.3

8.5

1.05

1.17

inr

2.02

151

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

645

1.34

1.20

6.7

7.3

1.22

mmol/l

0.04

561

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.15

1.20

3.1

3.3

50.10

51.88

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

1.16

0.0

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

335

1.40

1.12

4.5

3.2

—

(36304419) Bacteria [Presence] in Urine

396

0.69

1.06

3.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

321

1.39

1.05

1.9

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.30

1.04

1.0

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.30

1.04

1.0

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

160

1487

1.37

1.01

5.3

4.3

1.80

1.82

mu/l

0.06

152

1390

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.97

0.0

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

176

1.48

0.96

3.3

3.4

25.72

21.64

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.79

0.92

1.1

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

140

0.55

0.86

9.3

10.4

25.90

24.84

mmol/l

—

140

(3035637) Corticotropin [Mass/volume] in Plasma

1.96

0.85

1.7

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.68

0.83

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

156

1.46

0.83

1.4

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

128

1385

0.79

0.82

6.2

8.6

92.23

94.94

ml/min/173m2

0.80

101

1051

(3003694) ABO and Rh group [Type] in Blood

525

0.77

1.5

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

133

1.47

0.77

1.5

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

384

0.74

0.75

3.1

0.25

0.27

e6/l

0.06

282

(40761511) CBC panel - Blood by Automated count

181

1737

1.42

0.74

10.8

9.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1.87

0.74

1.6

1.5

6.66

22.52

u/l

—

(3022948) Iron [Moles/volume] in Serum or Plasma

216

0.67

0.74

3.1

2.6

16.02

14.41

umol/l

0.44

203

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

181

0.64

0.73

2.7

26.00

24.70

—

158

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.78

0.72

1.1

1.6

1.40

0.23

nmol/l

—

(3025941) Bacteria identified in Stool by Culture

1.57

0.71

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.58

0.71

1.7

1.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1.53

0.69

5.2

6.6

70.50

68.58

ng/l

0.04

(3048689) Calprotectin [Mass/mass] in Stool

279

1.31

0.68

1.6

2.5

77.79

82.34

ug/g

0.06

214

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

198

1.36

0.68

2.2

2.8

167.65

337.35

ng/l

0.54

114

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.64

0.66

1.2

1.1

—

18.35

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

129

0.60

0.66

1.6

1.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.51

0.66

1.7

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

138

1.42

0.65

1.6

1.7

—

(4035726) Immunohistochemistry procedure

101

0.58

0.64

3.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

197

0.69

0.62

2.5

2.61

2.51

g/l

0.39

179

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

211

1.32

0.61

6.2

3.1

688.64

621.24

ng/l

0.06

170

(3022096) Basophils/100 leukocytes in Blood

779

0.83

0.61

7.2

6.4

0.66

0.03

741

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.60

0.0

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.60

0.0

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.60

0.0

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.59

0.0

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.59

0.0

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.59

0.0

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.59

0.0

2.8

—

17.20

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

116

1072

1.19

0.58

3.5

3.2

30.69

37.23

u/l

0.82

109

1024

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

171

0.68

0.57

1.3

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.55

0.55

6.6

11.2

—

(3044290) Cell count panel - Cerebral spinal fluid

1.60

0.55

1.0

2.5

—

(3018095) Leukocytes [#/volume] in Urine

504

0.81

0.54

3.1

3.6

42.82

44.11

e6/l

0.01

341

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

496

1.21

0.54

4.9

3.2

24.06

28.59

u/l

2.59

474

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

133

0.66

0.54

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

191

0.71

0.54

2.2

2.4

2.40

2.44

mmol/l

0.51

164

(3016502) Oxygen saturation in Arterial blood

1.44

0.52

7.0

11.2

97.94

96.80

0.60

(3006504) Eosinophils/100 leukocytes in Blood

810

0.84

0.51

6.8

6.3

3.01

2.83

0.29

773

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

101

1.42

0.51

2.1

2.3

—

19.72

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

143

1501

0.84

0.50

3.2

3.6

—

(3052851) Hemolysis interference index of Serum or Plasma

1.51

0.48

1.7

3.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.63

0.43

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.63

0.43

1.4

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

223

1.24

0.42

1.7

1.8

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.41

0.0

9.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.41

0.0

1.2

—

(3011648) Oxygen content in Venous blood

0.00

0.41

0.0

19.6

—

12.93

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.41

0.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.14

—

(3036180) Methadone [Presence] in Urine

0.00

0.41

0.0

2.1

—

(1761868) Lipid panel - Serum or Plasma

552

0.85

0.41

2.4

2.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.40

0.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

181

0.76

0.40

2.1

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

188

1.25

0.39

1.6

1.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.44

0.39

1.2

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.40

0.38

1.2

1.5

—

(3000991) Gas panel - Venous blood

134

1.29

0.38

5.5

10.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.34

0.38

2.7

1.9

—

(36660697) Celiac disease serology panel - Serum

208

1.23

0.37

1.3

1.2

—

(3000492) Spirometry study

144

1.27

0.37

1.3

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

446

1.16

0.36

1.9

1.7

105.71

97.31

pmol/l

0.45

238

(3008898) HLA-B27 [Presence]

117

1.30

0.36

1.1

—

(3036489) Thrombin time

0.62

0.36

7.2

5.0

21.80

21.47

—

(3019069) Monocytes/100 leukocytes in Blood

812

0.88

0.36

7.0

6.5

8.65

8.18

0.66

778

(3002523) Influenza virus A Ag [Presence] in Specimen

1.41

0.35

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.41

0.35

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1.34

0.34

1.0

2.2

291.17

359.07

mg/l

—

(3022145) Colonoscopy Study observation

137

1.26

0.33

1.0

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

230

1.20

0.33

1.4

1.5

466.67

523.77

titre

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

165

1.24

0.32

1.2

23.91

139.31

iu/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.32

0.32

1.1

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

803

1.12

0.32

4.3

4.8

6.21

6.30

mmol/l

0.16

727

(40761536) Microorganisms panel - Urine sediment

131

0.75

0.32

2.8

3.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

0.76

0.30

2.3

1.5

—

(40768443) Skin Pathology biopsy report

1.26

0.29

1.0

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.26

0.29

1.3

8.1

0.80

0.66

—

(40768797) Stomach Pathology biopsy report

161

0.79

0.28

1.4

1.3

—

(3011288) Drugs identified in Urine by Screen method

117

0.76

0.28

1.7

2.5

—

(3016879) Cocaine [Presence] in Urine

139

0.78

0.28

1.3

2.1

—

(3013512) EKG study

309

0.85

0.28

2.7

2.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

436

1.13

0.27

2.7

—

(3012516) Albumin [Mass/volume] in Urine

263

1.17

0.27

2.8

3.2

2526.87

100.24

mg/l

0.46

180

(3002030) Lymphocytes/100 leukocytes in Blood

851

0.90

0.27

6.4

6.2

32.91

30.98

0.95

819

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

307

0.86

0.26

1.2

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

168

1642

1.14

0.24

11.2

10.1

18.32

20.24

mg/l

0.31

120

1203

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.25

0.23

2.3

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

267

1.15

0.23

1.7

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.29

0.23

1.2

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

834

0.91

0.22

6.1

6.0

52.75

54.82

0.88

800

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.5

—

0.65

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

0.85

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

15.69

—

(40768446) Kidney Pathology biopsy report

0.00

0.21

0.0

1.6

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

9.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

1.2

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.21

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.21

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.21

0.0

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

2.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.21

0.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

2.5

—

3.85

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

2.5

—

106.17

—

(40768800) Prostate Pathology biopsy report

0.00

0.21

0.0

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

138

1340

1.10

0.21

3.6

3.2

1.17

1.22

mmol/l

0.40

132

1257

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.21

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.3

—

12.42

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

143

1394

1.09

0.18

3.9

3.5

1.51

1.48

mmol/l

0.45

138

1312

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.21

0.18

1.3

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

309

0.89

0.18

1.6

1.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

467

1.09

0.18

3.1

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

236

0.88

0.18

2.5

2.7

1.36

0.84

e6/l

0.82

127

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.17

0.16

1.0

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

389

0.91

0.16

1.3

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.76

0.16

1.8

—

(3013115) Eosinophils [#/volume] in Blood

876

1.07

0.16

6.5

7.0

0.19

e9/l

0.09

778

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.74

0.15

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.74

0.15

1.2

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.74

0.15

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.74

0.15

1.2

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

141

1.15

0.14

1.1

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

149

0.86

0.14

1.2

1.5

—

(3027944) Amphetamines [Presence] in Urine

149

0.86

0.14

1.2

2.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

304

0.91

0.14

1.3

13.07

30.14

iu/ml

—

(3019225) pH of Specimen

0.80

0.14

4.4

4.1

—

(3042936) Bacteria identified in Isolate by Culture

181

1.12

0.12

1.6

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

133

1.14

0.12

2.7

2.3

0.62

0.73

ug/l

—

(40768804) Tissue Pathology biopsy report

536

1.06

0.11

1.7

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

576

1.06

0.11

1.8

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.11

0.10

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.09

0.09

1.2

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.09

0.09

2.6

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.07

0.09

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

410

1.06

0.09

2.7

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

501

0.94

0.09

1.8

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.04

0.09

2.6

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.09

0.09

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.04

0.08

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.82

0.08

1.0

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

0.89

0.08

1.3

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.84

0.08

1.3

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

383

1.06

0.07

2.6

3.2

7.93

8.20

mmol/l

0.11

352

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.04

0.07

1.1

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.87

0.07

7.7

5.3

9.76

9.58

kpa

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

103

0.87

0.06

2.1

3.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

544

1.04

0.06

1.5

1.29

1.42

u/ml

0.09

143

(3013650) Neutrophils [#/volume] in Blood by Automated count

963

1.03

0.06

7.4

9.1

3.64

3.85

e9/l

0.49

835

(3023368) Bacteria identified in Blood by Culture

273

0.95

0.05

2.3

4.4

—

(3028300) Cannabinoids [Presence] in Urine

150

0.93

0.04

1.2

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

422

0.96

0.04

2.7

2.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

189

1881

1.08

0.03

16.1

15.3

40.81

40.51

0.29

164

1779

(3027008) Opiates [Presence] in Urine

149

0.94

0.03

1.2

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

888

1.02

0.03

6.4

6.2

1.96

2.11

e9/l

0.47

793

(3000764) Benzodiazepines [Presence] in Urine

148

0.94

0.02

1.2

2.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

117

0.94

0.02

1.5

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

392

1.03

0.01

2.6

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

254

1.03

0.00

1.5

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

106

1.04

0.00

7.5

9.7

25.09

23.71

mmol/l

1.12

106

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

706

1.01

0.00

2.5

—

(3001604) Monocytes [#/volume] in Blood

849

1.00

0.00

6.5

6.3

0.52

0.54

e9/l

0.25

740

(3020682) Albumin/Creatinine [Ratio] in Urine

275

1.02

0.00

3.3

3.8

4.25

15.46

mg/mmol

1.41

178

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

295

1.02

0.00

1.3

1.50

7.90

u/ml

1.89

121

(3014576) Chloride [Moles/volume] in Serum or Plasma

132

0.98

0.00

4.3

8.6

105.77

104.92

mmol/l

0.33

132

(3022313) Gas panel - Capillary blood

102

0.98

0.00

7.2

5.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

0.68

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

12.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.98

0.00

1.2

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

5.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3006270) Folate [Moles/volume] in Blood

0.00

0.0

1.3

—

468.50

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

1.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.97

0.00

1.0

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3006462) Nitrate [Presence] in Urine

0.00

0.0

1.3

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.2

—

(3022621) pH of Urine by Test strip

0.91

0.00

2.6

2.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

2.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.88

-0.00

1.2

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

7.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

3.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1377.14

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.1

—

6.19

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

130

1.00

-0.00

1.9

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.94

-0.00

2.9

1.6

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

2.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

800

1.00

-0.00

7.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

4.7

—

201.78

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3004451) EKG impression Narrative

0.00

-0.00

0.0

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.63

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

9.22

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.1

—

531.43

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

69.38

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

4.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.4

—

15.20

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

60.44

—

(3045414) Leukocytes [Presence] in Urine

0.89

-0.00

3.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

14.0

—

(3006315) Basophils [#/volume] in Blood

850

1.00

-0.00

6.5

6.3

0.04

e9/l

0.33

740

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

-0.00

0.0

1.4

—

34.10

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.92

-0.00

6.7

5.9

164.17

163.09

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

0.88

-0.00

1.2

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3034426) Prothrombin time (PT)

0.00

-0.00

0.0

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

4.9

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

3.82

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.6

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.58

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.1

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

2.3

—

(3045716) Anion gap in Serum or Plasma

0.00

-0.00

0.0

1.0

—

8.00

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.09

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MAXIL_PROGN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MAXIL_PROGN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_MAXIL_PROGN – Maxillary prognathism

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Maxillary prognathism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints